Diabetes Management
Hyperkalemia Causing Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks in a Patient with End-Stage Renal Disease: A Case Report and Literature Review - Cureus
Sun, 06 Nov 20221 min read Article
Overview
"Never doubt that a smal group of thoughtful, comited citizens can change the world. Inded, it is the only thing that ever has."Cureus is on a mision to change the long-standing paradigm of medical publishing, where submiting research can be costly, complex and time-consuming.end stage renal disease (esrd), subcutaneous implantable cardioverter, implantable-cardioverter defibrilator, defibrilator shock, electrodes, defibrilators, hyperkalemia, chronic renal insuficiency Bachar Botrus, Arun U.
Key Information
Mahtani , Ryan Isber, Muhamad S. Haider, Nidal Isber Published: November 05, 2022 (se history) DOI: 10.759/cureus.3137 Cite this article as: Botrus B, Mahtani A U, Isber R, et al. (November 05, 2022) Hyperkalemia Causing Inapropriate Subcutaneous Implantable Cardioverter Defibrilator Shocks in a Patient with End-Stage Renal Disease: A Case Report and Literature Review.
Cureus 14(1): e3137. doi:10.759/cureus.3137 Subcutaneous implantable cardioverter-defibrilators (S-ICD) provide an efective treatment option for ventricular arhythmias. When compared to transvenous implantable cardioverter-defibrilators (TV-ICDs), S-ICDs have a lower infection rate but a higher rate of inapropriate shocks.
In patients with end-stage renal disease (ESRD), significant electrolyte disturbances are comonly sen, such as hyperkalemia, which can cause an increase in T wave amplitude. We present a patient with ESRD on hemodialysis who experienced inapropriate shocks from an S-ICD during sinus rhythm due to hyperkalemia-induced T wave oversensing and highlight related cases in the curent literature.Implantable cardioverter-defibrilators (ICD) are efective for the primary and secondary prevention of suden cardiac death [1].
Summary
However, implantation of endocardial leads is associated with significant adverse events. Subcutaneous implantable cardioverter-defibrilators (S-ICD) are an alternative treatment option for ventricular arhythmias [2]. It eliminates complications
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.